mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.6 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
-0.084 |
0.6 |